We are, and will remain, perpetual newbies. - Kevin Kelly
WRITTEN BY Kathy Huang
2021 BioJapan Highlights: How Can Metabolomics and Lipidomics Deepen Microbiome Research?
Zai Lab, Turning Point’s Solid Tumor Treatment Repotrectinib Gets FDA Breakthrough Therapy Designation
Taiwan’s Biotech Industry, Lackluster or Late Bloomer? A Breakdown of Policies, Hotspots, and Market Movements
CYTENA Bioprocess Solutions Closes $5M Funding to Develop Automatic High-throughput Screening Platform for Pharmaceuticals
Revealing the Underestimated Potential of Natural RNA Editing – An Interview with Dr. Trees-Juen Chuang
Current Challenges and Future Opportunities of Artificial RNA Editing – An Interview with Professor Toshifumi Tsukahara